Market Tracker

06/23 11:29am ET

Novelion Therapeutics Inc (NASDAQ:NVLN)

10.16
Delayed Data
As of 11:13am ET
 -0.015 / -0.15%
Today’s Change
6.10
Today|||52-Week Range
13.80
+20.72%
Year-to-Date
No recent news for Novelion Therapeutics Inc.

Today’s Trading

Previous close10.18
Today’s open10.16
Day’s range10.12 - 10.41
Volume14,868
Average volume (3 months)96,273
Market cap$189.4M
Dividend yield37.85%
Data as of 11:13am ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-113.18%
Earnings growth (this year)+88.50%
Earnings growth (next 5 years)+74.60%
Revenue growth (last year)--
P/E ratioNM
Price/Sales7.00
Price/Book1.39

Competitors

 Today’s
change
Today’s
% change
CDXCChromadex Corp+0.04+1.09%
NATRNatures Sunshine Pro...-0.10-0.75%
CDTXCidara Therapeutics ...0.000.00%
CTSOCytosorbents Corp+0.13+3.05%
Data as of 11:28am ET, 06/23/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$13.6M
Annual profit (last year)-$52.9M
Net profit margin-389.49%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mary J. Szela
Director, Chief Financial &
Administrative Officer
Gregory D. Perry
Corporate headquarters
Vancouver, British Columbia

Forecasts